Edition:
United Kingdom

People: Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

9.75CNY
18 Apr 2019
Change (% chg)

¥-0.43 (-4.22%)
Prev Close
¥10.18
Open
¥9.94
Day's High
¥10.05
Day's Low
¥9.70
Volume
118,424,541
Avg. Vol
102,222,565
52-wk High
¥11.28
52-wk Low
¥5.62

Wang, Ruwei 

Mr. Wang Ruwei has been serving as President and Director in Zhejiang CONBA Pharmaceutical Co., Ltd. since May 11, 2017. He used to serve as Director of Research and Development in the Company, General Manager of a medical research and development company, and General Manager-Botanical Medicine Business and Deputy General Manager in a Zhejiang-based medicine sales company.

Basic Compensation

Total Annual Compensation, CNY --
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 579,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jiqiang Hu

200,000

Ruwei Wang

579,900

Wei Liang Zhang

757,700

Zhenxian Yuan

--

Yuezhong Chen

--

Junde Yang

470,800
As Of  31 Dec 2012